Skip to main content

S32 — Portfolio

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

102
Companies
$4.6B
Total invested
$50.0M
Avg. check
34
Industries
Biotechnology 12Artificial Intelligence (AI) 10Health Care 8Medical 6Therapeutics 5Software 4+28 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 1–24 of 102
ScienceIO
August 2023

ScienceIO develops a biomedical language platform to transform complex medical text into usable data and actionable insights.

Analytics · Boston$8.0M Series A
Linear
August 2026

Linear is a purpose-built tool for tracking issues, managing sprints, and organizing project roadmaps in software development teams.

Artificial Intelligence (AI) · San Francisco$99.0M Secondary Market
Faro AI
August 2026

Faro Health develops software to assists clinical development processes, including workflow automation and clinical trial design.

Artificial Intelligence (AI) · La Jolla$37.3M Series B
Spectral
August 2022

Spectral is a protocol for programmable creditworthiness.

Blockchain · New Rochelle$23.0M Venture - Series Unknown
Network Bio
August 2026

Network Bio develops AI platforms designed to learn from human biology and support medical research and healthcare applications.

Artificial Intelligence (AI) · New York$50.0M Venture - Series Unknown
BigHat Biosciences
July 2022

BigHat Biosciences is a protein therapeutics company that develops an antibody design platform guided by artificial intelligence.

Artificial Intelligence (AI) · San Mateo$75.0M Series B
Owl AI
June 2025

Owl AI is a sports technology company that uses artificial intelligence to improve performance analytics and decision-making in sports.

Analytics · San Francisco$11.0M Seed
AltPep
June 2023

AltPep provides a novel approach for tackling amyloid diseases, with diagnostic, therapeutic and anti-biofilm applications.

Biotechnology · Seattle$52.9M Series B
Delve Bio
June 2023

Delve Bio is a biotechnology company that provides molecular insights for the precision care of patients.

Biotechnology · San Francisco$35.0M Series A
Inductive Bio
May 2025

Inductive Bio provides the information, machine learning, tools, and know-how required to resolve ADMET issues.

Biotechnology · San Francisco$25.0M Series A
Relay Therapeutics
May 2026

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.

Biotechnology · Cambridge$275.0M Post-IPO Equity
MOMA Therapeutics
May 2022

MOMA Therapeutics operates as a biotechnology company.

Biotechnology · Cambridge$150.0M Series B
Function Oncology
April 2023

Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform.

Biotechnology · San Diego$28.0M Series A
Satellite Bio
March 2022

Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.

Biopharma · Newton$82.5M Series A
Celsius Therapeutics
March 2022

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.

Biotechnology · Cambridge$83.0M Series B
Autoscience
March 2026

Autoscience uses science and tech to improve vehicle automation, safety, and performance.

San Mateo$14.0M Seed
RunSybil
March 2026

RunSybil is an AI-powered offensive security platform designed to continuously test applications and infrastructure for vulnerabilities.

Artificial Intelligence (AI) · San Francisco$40.0M Seed
MedCrypt
February 2025

MedCrypt is a medical device company that provides data security as a service to medical device OEMs.

Health Care · Solana Beach$8.3M Debt Financing
Phaidra
October 2025

Phaidra provides AI and ML solutions to accelerate performance in large-scale industries.

Artificial Intelligence (AI) · Seattle$50.0M Series B
Character Biosciences
September 2025

Character Bio is a platform that merges genomics with clinical data and AI technology, focusing on patients affected by AMD.

Artificial Intelligence (AI) · Jersey City$17.0M Series B
Endor Labs
April 2025

Endor Labs secures software supply chains with advanced tools for open-source risk, compliance, and developer productivity.

Cyber Security · Palo Alto$93.0M Series B
Octave
March 2025

Octave is a biotechnology company that uses precision medicine and scientific insights to treat patients with multiple sclerosis.

Biotechnology · Menlo Park$31.8M Series C
Sola Security
March 2025

Sola Security provides a self-serve cybersecurity platform that enables organizations to build, customize, and manage security tools.

Artificial Intelligence (AI) · Tel Aviv-jaffa$30.0M Seed
Meatable
November 2024

Meatable is a food production company that produces guilt-free meat.

Food and Beverage · LeidenVenture - Series Unknown

Where S32 invests

Biotechnology12
Artificial Intelligence (AI)10
Health Care8
Medical6
Therapeutics5
Software4

About S32's portfolio

How many companies has S32 invested in?▸

S32 has invested in 102 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does S32 invest in?▸

S32's top investment sectors include Biotechnology, Artificial Intelligence (AI), Health Care, Medical, Therapeutics. The firm invests across 34 different industry categories.

What is S32's largest investment?▸

Among tracked funding rounds, Relay Therapeutics received $275.0M in a Post-IPO Equity round. S32's total known invested capital is $4.6B.

What is the average investment size for S32?▸

S32's average investment size is $50.0M across its portfolio of 102 companies.

What are S32's most recent investments?▸

Recent S32 portfolio additions include ScienceIO, Linear, Faro AI, Spectral, Network Bio. These companies were founded in 2020 or later.

Reach the founders behind these 102 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →